Epigenetic control of autophagy by MicroRNAs in ovarian cancer

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Titone, Rossella ^a   Morani, Federica ^a   Follo, Carlo ^a   Vidoni, Chiara ^a   Mezzanzanica, Delia ^b   Isidoro, Ciro ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 5; B RAF KINASE; BECLIN 1; K RAS PROTEIN; LET 7A; MICRORNA; MICRORNA 100; MICRORNA 101; MICRORNA 125B; MICRORNA 141; MICRORNA 155; MICRORNA 15A; MICRORNA 15B; MICRORNA 182; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 214; MICRORNA 31; MICRORNA 34A; MICRORNA 449B; MICRORNA 99A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; RNA;

AUTOPHAGY; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL METABOLISM; CELL SURVIVAL; CHEMOSENSITIVITY; COLLOID CARCINOMA; ENDOMETRIOID CARCINOMA; ENVIRONMENTAL STRESS; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; OVARY CANCER; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; STROMA CELL; ANIMAL; FEMALE; GENETIC EPIGENESIS; METABOLISM; OVARY TUMOR;

ANIMALS; AUTOPHAGY; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; RNA, NEOPLASM;

EID: 84901249220     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/343542     Document Type: Review

References (118)

1. Vaughan S., Coward J. I., Bast R. C. Jr., Rethinking ovarian cancer: recommendations for improving outcomes. Nature Reviews Cancer 2011 11 10 719 725 10.1038/nrc3144
2. Steeves M. A., Dorsey F. C., Cleveland J. L., Targeting the autophagy pathway for cancer chemoprevention. Current Opinion in Cell Biology 2010 22 2 218 225 2-s2.0-77951233877 10.1016/j.ceb.2009.12.013
3. Chen N., Karantza V., Autophagy as a therapeutic target in cancer. Cancer Biology and Therapy 2011 11 2 157 168 2-s2.0-78751556979 10.4161/cbt.11.2.14622
4. Lee S. K., Calin G. A., Non-coding RNAs and cancer: new paradigms in oncology. Discovery Medicine 2011 11 58 245 254 2-s2.0-79960127278
5. Valencia-Sanchez M. A., Liu J., Hannon G. J., Parker R., Control of translation and mRNA degradation by miRNAs and siRNAs. Genes and Development 2006 20 5 515 524 2-s2.0-33644768174 10.1101/gad.1399806 (Pubitemid 43345317)
6. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 2-s2.0-38349169664 10.1038/nrg2290
7. Garzon R., Calin G. A., Croce C. M., MicroRNAs in cancer. Annual Review of Medicine 2009 60 167 179 2-s2.0-67650711156 10.1146/annurev.med.59.053006. 104707
8. Cortez M. A., Ivan C., Zhou P., Wu X., Ivan M., Adrian Calin G., MicroRNAs in cancer: from bench to bedside. Advances in Cancer Research 2010 108 113 157 2-s2.0-77958449792 10.1016/B978-0-12-380888-2.00004-2
9. Nana-Sinkam S. P., Croce C. M., MicroRNAs as therapeutic targets in cancer. Translational Research 2011 157 4 216 225 2-s2.0-79952783987 10.1016/j.trsl.2011.01.013
10. Mizushima N., Levine B., Autophagy in mammalian development and differentiation. Nature Cell Biology 2010 12 9 823 830 2-s2.0-77956416339 10.1038/ncb0910-823
11. Yang Z., Klionsky D. J., Eaten alive: a history of macroautophagy. Nature Cell Biology 2010 12 9 814 822 2-s2.0-77956404377 10.1038/ncb0910-814
12. Yang Z., Klionsky D. J., Mammalian autophagy: core molecular machinery and signaling regulation. Current Opinion in Cell Biology 2010 22 2 124 131 2-s2.0-77951214016 10.1016/j.ceb.2009.11.014
13. Orenstein S. J., Cuervo A. M., Chaperone-mediated autophagy: molecular mechanisms and physiological relevance. Seminars in Cell and Developmental Biology 2010 21 7 719 726 2-s2.0-77956178939 10.1016/j.semcdb.2010.02.005
14. Sahu R., Kaushik S., Clement C. C., Cannizzo E. S., Scharf B., Follenzi A., Potolicchio I., Nieves E., Cuervo A. M., Santambrogio L., Microautophagy of cytosolic proteins by late endosomes. Developmental Cell 2011 20 1 131 139 2-s2.0-78651423598 10.1016/j.devcel.2010.12.003
15. Mizushima N., Komatsu M., Autophagy: renovation of cells and tissues. Cell 2011 147 4 728 741 2-s2.0-81055144784 10.1016/j.cell.2011.10.026
16. Ravikumar B., Sarkar S., Davies J. E., Regulation of mammalian autophagy in physiology and pathophysiology. Physiological Reviews 2010 90 4 1383 1435 10.1152/physrev.00030.2009
17. Itakura E., Mizushima N., Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins. Autophagy 2010 6 6 764 776 2-s2.0-77955884684 10.4161/auto.6.6.12709
18. Kim P. K., Hailey D. W., Mullen R. T., Lippincott-Schwartz J., Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proceedings of the National Academy of Sciences of the United States of America 2008 105 52 20567 20574 2-s2.0-58549084167 10.1073/pnas.0810611105
19. Kirkin V., McEwan D. G., Novak I., Dikic I., A role for ubiquitin in selective autophagy. Molecular Cell 2009 34 3 259 269 2-s2.0-65549142204 10.1016/j.molcel.2009.04.026
20. Hanna R. A., Quinsay M. N., Orogo A. M., Giang K., Rikka S., Gustafsson Å. B., Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 proteinto selectively remove endoplasmic reticulum and mitochondria via autophagy. The Journal of Biological Chemistry 2012 287 23 19094 19104
21. Klionsky D. J., Abdalla F. C., Abeliovich H., Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012 8 4 445 544
22. Axe E. L., Walker S. A., Manifava M., Chandra P., Roderick H. L., Habermann A., Griffiths G., Ktistakis N. T., Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. Journal of Cell Biology 2008 182 4 685 701 2-s2.0-50249084987 10.1083/jcb.200803137
23. Korolchuk V. I., Saiki S., Lichtenberg M., Siddiqi F. H., Roberts E. A., Imarisio S., Jahreiss L., Sarkar S., Futter M., Menzies F. M., O'Kane C. J., Deretic V., Rubinsztein D. C., Lysosomal positioning coordinates cellular nutrient responses. Nature Cell Biology 2011 13 4 453 462 2-s2.0-79953316595 10.1038/ncb2204
24. Tong J., Yan X., Yu L., The late stage of autophagy: cellular events and molecular regulation. Protein and Cell 2010 1 10 907 915 2-s2.0-79953153833 10.1007/s13238-010-0121-z
25. Feng Y., He D., Yao Z., Klionsky D. J., The machinery of macroautophagy. Cell Research 2014 24 1 24 41
26. Ogier-Denis E., Couvineau A., Maoret J. J., Houri J. J., Bauvy C., De Stefanis D., Isidoro C., Laburthe M., Codogno P., A heterotrimeric Gi3 -protein controls autophagic sequestration in the human colon cancer cell line HT-29. The Journal of Biological Chemistry 1995 270 1 13 16 2-s2.0-0028985249 10.1074/jbc.270.1.13
27. Chen Y., Klionsky D. J., The regulation of autophagy-unanswered questions. Journal of Cell Science 2011 124 2 161 170 2-s2.0-79251577061 10.1242/jcs.064576
28. Mizushima N., The role of the Atg1/ULK1 complex in autophagy regulation. Current Opinion in Cell Biology 2010 22 2 132 139 2-s2.0-77951221542 10.1016/j.ceb.2009.12.004
29. Alers S., Löffler A. S., Wesselborg S., Stork B., Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Molecular and Cellular Biology 2012 32 1 2 11 2-s2.0-84856800302 10.1128/MCB.06159-11
30. Yuan H. X., Russell R. C., Guan K. L., Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy. Autophagy 2013 9 12
31. He C., Levine B., The Beclin 1 interactome. Current Opinion in Cell Biology 2010 22 2 140 149 2-s2.0-77951237303 10.1016/j.ceb.2010.01.001
32. McAlpine F., Williamson L. E., Tooze S. A., Chan E. Y., Regulation of nutrient-sensitive autophagy by uncoordinated 51-like kinases 1 and 2. Autophagy 2013 9 3 361 373
33. Alexander A., Cai S.-L., Kim J., Nanez A., Sahin M., MacLean K. H., Inoki K., Guan K.-L., Shen J., Person M. D., Kusewitt D., Mills G. B., Kastan M. B., Walker C. L., ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proceedings of the National Academy of Sciences of the United States of America 2010 107 9 4153 4158 2-s2.0-77749233738 10.1073/pnas. 0913860107
34. Janda E., Isidoro C., Carresi C., Mollace V., Defective autophagy in Parkinson's disease: role of oxidative stress. Molecular Neurobiology 2012 46 3 639 661
35. Castino R., Fiorentino I., Cagnin M., Giovia A., Isidoro C., Chelation of lysosomal iron protects dopaminergic SH-SY5Y neuroblastoma cells from hydrogen peroxide toxicity by precluding autophagy and Akt dephosphorylation. Toxicological Sciences 2011 123 2 523 541 2-s2.0-80053450324 10.1093/toxsci/kfr179
36. Mathew R., Kongara S., Beaudoin B., Autophagy suppresses tumor progression by limiting chromosomal instability. Genes and Development 2007 21 1367 1381 (Pubitemid 46871040)
37. Semenza G. L., American Journal of Physiology-Cell Physiology theme: hypoxia. American Journal of Physiology-Cell Physiology 2011 300 2 C225 2-s2.0-79251549460 10.1152/ajpcell.00468.2010
38. Mathew R., Karp C. M., Beaudoin B., Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009 137 1062 1075
39. Young A. R. J., Narita M., Ferreira M., Kirschner K., Sadaie M., Darot J. F. J., Tavaré S., Arakawa S., Shimizu S., Watt F. M., Narita M., Autophagy mediates the mitotic senescence transition. Genes and Development 2009 23 7 798 803 2-s2.0-64349123107 10.1101/gad.519709
40. Lu Z., Luo R. Z., Lu Y., Zhang X., Yu Q., Khare S., Kondo S., Kondo Y., Yu Y., Mills G. B., Liao W. S.-L., Bast R. C. Jr., The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. The Journal of Clinical Investigation 2008 118 12 3917 3929 2-s2.0-57449121645 10.1172/JCI35512
41. Sanchez C. G., Penfornis P., Oskowitz A. Z., Boonjindasup A. G., Cai D. Z., Dhule S. S., Rowan B. G., Kelekar A., Krause D. S., Pochampally R. R., Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 2011 32 7 964 972 2-s2.0-79960046702 10.1093/carcin/bgr029
42. Maiuri M. C., Tasdemir E., Criollo A., Morselli E., Vicencio J. M., Carnuccio R., Kroemer G., Control of autophagy by oncogenes and tumor suppressor genes. Cell Death and Differentiation 2009 16 1 87 93 2-s2.0-57649184088 10.1038/cdd.2008.131
43. Yoo B. H., Wu X., Li Y., Haniff M., Sasazuki T., Shirasawa S., Eskelinen E.-L., Rosen K. V., Oncogenic ras-induced down-regulation of autophagy mediator Beclin-1 is required for malignant transformation of intestinal epithelial cells. The Journal of Biological Chemistry 2010 285 8 5438 5449 2-s2.0-77949324323 10.1074/jbc.M109.046789
44. Kim M.-J., Woo S.-J., Yoon C.-H., Lee J.-S., An S., Choi Y.-H., Hwang S.-G., Yoon G., Lee S.-J., Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation. The Journal of Biological Chemistry 2011 286 15 12924 12932 2-s2.0-79953856887 10.1074/jbc.M110.138958
45. Guo J. Y., Chen H.-Y., Mathew R., Fan J., Strohecker A. M., Karsli-Uzunbas G., Kamphorst J. J., Chen G., Lemons J. M. S., Karantza V., Coller H. A., DiPaola R. S., Gelinas C., Rabinowitz J. D., White E., Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes and Development 2011 25 5 460 470 2-s2.0-79952228407 10.1101/gad.2016311
46. Elgendy M., Sheridan C., Brumatti G., Martin S. J., Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. Molecular Cell 2011 42 1 23 35 2-s2.0-79953306808 10.1016/j.molcel.2011.02.009
47. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., Rosen J., Eskelinen E.-L., Mizushima N., Ohsumi Y., Cattoretti G., Levine B., Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. The Journal of Clinical Investigation 2003 112 12 1809 1820 2-s2.0-9144240441 10.1172/JCI200320039 (Pubitemid 38063704)
48. Yue Z., Jin S., Yang C., Levine A. J., Heintz N., Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 15077 15082 2-s2.0-0345166111 10.1073/pnas.2436255100 (Pubitemid 37518019)
49. di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P. P., Pten is essential for embryonic development and tumour suppression. Nature Genetics 1998 19 4 348 355 2-s2.0-0031870959 10.1038/1235 (Pubitemid 28357906)
50. Podsypanina K., Ellenson L. H., Nemes A., Gu J., Tamura M., Yamada K. M., Cordon-Cardo C., Catoretti G., Fisher P. E., Parsons R., Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proceedings of the National Academy of Sciences of the United States of America 1999 96 4 1563 1568 2-s2.0-13044250465 10.1073/pnas.96.4.1563 (Pubitemid 29098491)
51. Crighton D., Wilkinson S., O'Prey J., Syed N., Smith P., Harrison P. R., Gasco M., Garrone O., Crook T., Ryan K. M., DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006 126 1 121 134 2-s2.0-33745885329 10.1016/j.cell.2006.05.034 (Pubitemid 44040988)
52. Tasdemir E., Maiuri M. C., Galluzzi L., Vitale I., Djavaheri-Mergny M., D'Amelio M., Criollo A., Morselli E., Zhu C., Harper F., Nannmark U., Samara C., Pinton P., Vicencio J. M., Carnuccio R., Moll U. M., Madeo F., Paterlini-Brechot P., Rizzuto R., Szabadkai G., Pierron G., Blomgren K., Tavernarakis N., Codogno P., Cecconi F., Kroemer G., Regulation of autophagy by cytoplasmic p53. Nature Cell Biology 2008 10 6 676 687 2-s2.0-44649141966 10.1038/ncb1730 (Pubitemid 351772933)
53. Morselli E., Tasdemir E., Maiuri M. C., Galluzzi L., Kepp O., Criollo A., Vicencio J. M., Soussi T., Kroemer G., Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008 7 19 3056 3061 2-s2.0-53649086181
54. Castino R., Bellio N., Follo C., Murphy D., Isidoro C., Inhibition of Pi3k class III-dependent autophagy prevents apoptosis and necrosis by oxidative stress in dopaminergic neuroblastoma cells. Toxicological Sciences 2010 117 1 152 162 2-s2.0-77955865105 10.1093/toxsci/kfq170
55. Xu T., Su H., Ganapathy S., Yuan Z.-M., Modulation of autophagic activity by extracellular pH. Autophagy 2011 7 11 1316 1322 2-s2.0-80655130339 10.4161/auto.7.11.17785
56. Mariño G., Kroemer G., Ammonia: a diffusible factor released by proliferating cells that induces autophagy. Science Signaling 2010 3 124, article pe19 2-s2.0-77953849832 10.1126/scisignal.3124pe19
57. Kurman R. J., Shih I.-M., The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. American Journal of Surgical Pathology 2010 34 3 433 443 2-s2.0-77649219639 10.1097/PAS.0b013e3181cf3d79
58. Shih I.-M., Kurman R. J., Ovarian tumorigenesis- a proposed model based on morphological and molecular genetic analysis. American Journal of Pathology 2004 164 5 1511 1518 2-s2.0-1942469352 (Pubitemid 38529752)
59. Abubaker J., Bavi P., Al-Haqawi W., Jehan Z., Munkarah A., Uddin S., Al-Kuraya K. S., PIK3CA alterations in Middle Eastern ovarian cancers. Molecular Cancer 2009 8, article 51 2-s2.0-68949212362 10.1186/1476-4598-8-51
60. Okuda T., Sekizawa A., Purwosunu Y., Genetics of endometrial cancers. Obstetrics and Gynecology International 2010 2010 8 10.1155/2010/984013 984013
61. Kurman R. J., Shih I.-M., Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Human Pathology 2011 42 7 918 931 2-s2.0-79959328816 10.1016/j.humpath.2011.03.003
62. Bast R. C. Jr., Hennessy B., Mills G. B., The biology of ovarian cancer: new opportunities for translation. Nature Reviews Cancer 2009 9 6 415 428 2-s2.0-67649440886
63. Cancer Genome Atlas Research Network, Integrated genomic analyses of ovarian carcinoma. Nature 2011 474 609 615
64. Kalamanathan S., Bates V., Lord R., Green J. A., The mutational profile of sporadic epithelial ovarian carcinoma. Anticancer Research 2011 31 8 2661 2668 2-s2.0-79961189196
65. Peracchio C., Alabiso O., Valente G., Isidoro C., Involvement of autophagy in ovarian cancer: a working hypothesis. Journal of Ovarian Research 2012 5 1, article 22 10.1186/1757-2215-5-22
66. Shen Y., Li D.-D., Wang L.-L., Deng R., Zhu X.-F., Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008 4 8 1067 1068 2-s2.0-58149084586
67. Yoon J.-H., Her S., Kim M., Jang I.-S., Park J., The expression of damage-regulated autophagy modulator 2 (DRAM2) contributes to autophagy induction. Molecular Biology Reports 2012 39 2 1087 1093 2-s2.0-79955861286 10.1007/s11033-011-0835-x
68. Park S.-M., Kim K., Lee E.-J., Kim B.-K., Lee T. J., Seo T., Jang I.-S., Lee S.-H., Kim S., Lee J.-H., Park J., Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death. Biochemical and Biophysical Research Communications 2009 390 4 1340 1344 2-s2.0-70450257643 10.1016/j.bbrc.2009.10. 149
69. Yemelyanova A., Vang R., Kshirsagar M., Lu D., Marks M. A., Shih I. M., Kurman R. J., Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Modern Pathology 2011 24 9 1248 1253 2-s2.0-80052414827 10.1038/modpathol.2011.85
70. Ahmed A. A., Etemadmoghadam D., Temple J., Lynch A. G., Riad M., Sharma R., Stewart C., Fereday S., Caldas C., DeFazio A., Bowtell D., Brenton J. D., Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. Journal of Pathology 2010 221 1 49 56 2-s2.0-77950965840 10.1002/path.2696
71. Maiuri M. C., Galluzzi L., Morselli E., Kepp O., Malik S. A., Kroemer G., Autophagy regulation by p53. Current Opinion in Cell Biology 2010 22 2 181 185 2-s2.0-77951243028 10.1016/j.ceb.2009.12.001
72. Yaginuma Y., Westphal H., Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Research 1992 52 15 4196 4199 2-s2.0-0026760566
73. Bunkholt Elstrand M., Dong H. P., Ødegaard E., Holth A., Elloul S., Reich R., Tropé C. G., Davidson B., Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma. Human Pathology 2010 41 6 794 804 2-s2.0-77951975662 10.1016/j.humpath.2009.09.017
74. Lu Z., Luo R. Z., Peng H., Rosen D. G., Atkinson E. N., Warneke C., Huang M., Nishmoto A., Liu J., Liao W. S.-L., Yu Y., Bast R. C. Jr., Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clinical Cancer Research 2006 12 8 2404 2413 2-s2.0-33646411738 10.1158/1078-0432.CCR-05-1036
75. Feng W., Marquez R. T., Lu Z., Liu J., Lu K. H., Issa J.-P. J., Fishman D. M., Yu Y., Bast R. C. Jr., Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 2008 112 7 1489 1502 2-s2.0-41149093072 10.1002/cncr.23323 (Pubitemid 351441161)
76. Yu Y., Fujii S., Yuan J., Luo R. Z., Wang L., Bao J., Kadota M., Oshimura M., Dent S. R., Issa J.-P., Bast R. C. Jr., Epigenetic regulation of ARHI in breast and ovarian cancer cells. Annals of the New York Academy of Sciences 2003 983 268 277 2-s2.0-0037354548 (Pubitemid 36399339)
77. Yu Y., Luo R., Lu Z., Wei Feng W., Badgwell D., Issa J.-P., Rosen D. G., Liu J., Bast R. C. Jr., Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods in Enzymology 2006 407 455 468 2-s2.0-33744528546 10.1016/S0076-6879(05) 07037-0 (Pubitemid 43815969)
78. Jegga A. G., Schneider L., Ouyang X., Zhang J., Systems biology of the autophagy-lysosomal pathway. Autophagy 2011 7 5 477 489 2-s2.0-79955692998 10.4161/auto.7.5.14811
79. Hu W., Chan C. S., Wu R., Zhang C., Sun Y., Song J. S., Tang L. H., Levine A. J., Feng Z., Negative regulation of tumor suppressor p53 by microRNA miR-504. Molecular Cell 2010 38 5 689 699 2-s2.0-77953096272 10.1016/j.molcel.2010.05.027
80. Lei Z., Li B., Yang Z., Fang H., Zhang G.-M., Feng Z.-H., Huang B., Regulation of HIF-1 α and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 2009 4 10 2-s2.0-70449602451 10.1371/journal.pone.0007629 e7629
81. He L., Posttranscriptional regulation of PTEN dosage by noncoding RNAs. Science Signaling 2010 3 146, article pe39 2-s2.0-78049492101 10.1126/scisignal.3146pe39
82. Zhai H., Fesler A., Ju J., MicroRNA: a third dimension in autophagy. Cell Cycle 2013 12 2 246 250
83. Zhu H., Wu H., Liu X., Li B., Chen Y., Ren X., Liu C.-G., Yang J.-M., Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009 5 6 816 823 2-s2.0-69449097865
84. Yang X., Zhong X., Tanyi J. L., Shen J., Xu C., Gao P., Zheng T. M., DeMichele A., Zhang L., mir-30d regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells. Biochemical and Biophysical Research Communications 2013 431 617 622
85. Kovaleva V., Mora R., Park Y. J., Plass C., Chiramel A. I., Bartenschlager R., Do ner H., Stilgenbauer S., Pscherer A., Lichter P., Seiffert M., miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Research 2012 72 7 1763 1772 2-s2.0-84859404834 10.1158/0008-5472.CAN-11-3671
86. Huang Y., Guerrero-Preston R., Ratovitski E. A., Phospho-ΔNp63 α -dependent regulation of autophagic signaling through transcription and micro-RNA modulation. Cell Cycle 2012 11 6 1247 1259 2-s2.0-84858722180 10.4161/cc.11.6.19670
87. Tekirdag K. A., Korkmaz G., Ozturk D. G., Agami R., Gozuacik D., MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5. Autophagy 2013 9 3 374 385
88. Chen Y., Liersch R., Detmar M., The miR-290-295 cluster suppresses autophagic cell death of melanoma cells. Scientific Reports 2012 2, article 808 10.1038/srep00808
89. Comincini S., Allavena G., Palumbo S., Morini M., Durando F., Angeletti F., Pirtoli L., Miracco C., microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells. Cancer Biology & Therapy 2013 14 7 574 586
90. Xu N., Zhang J., Shen C., Luo Y., Xia L., Xue F., Xia Q., Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochemical and Biophysical Research Communications 2012 423 4 826 831
91. Korkmaz G., le Sage C., Tekirdag K. A., Agami R., Gozuacik D., miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy 2012 8 2 165 176 2-s2.0-84857252293
92. di Leva G., Croce C. M., The role of microRNAs in the tumorigenesis of ovarian cancer. Frontiers in Oncology 2013 3, article 153
93. Mezzanzanica D., Bagnoli M., de Cecco L., Valeri B., Canevari S., Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. International Journal of Biochemistry and Cell Biology 2010 42 8 1262 1272 2-s2.0-77954382910 10.1016/j.biocel.2009.12.017
94. Iorio M. V., Visone R., di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.-G., Alder H., Calin G. A., Ménard S., Croce C. M., MicroRNA signatures in human ovarian cancer. Cancer Research 2007 67 18 8699 8707 2-s2.0-34548746977 10.1158/0008-5472.CAN-07-1936 (Pubitemid 47437445)
95. Nam E. J., Yoon H., Kim S. W., Kim H., Kim Y. T., Kim J. H., Kim J. W., Kim S., MicroRNA expression profiles in serous ovarian carcinoma. Clinical Cancer Research 2008 14 9 2690 2695 2-s2.0-50849137458 10.1158/1078-0432.CCR-07- 1731
96. Zhang L., Volinia S., Bonome T., Calin G. A., Greshock J., Yang N., Liu C.-G., Giannakakis A., Alexiou P., Hasegawa K., Johnstone C. N., Megraw M. S., Adams S., Lassus H., Huang J., Kaur S., Liang S., Sethupathy P., Leminen A., Simossis V. A., Sandaltzopoulos R., Naomoto Y., Katsaros D., Gimotty P. A., DeMichele A., Huang Q., Bützow R., Rustgi A. K., Weber B. L., Birrer M. J., Hatzigeorgiou A. G., Croce C. M., Coukos G., Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 2008 105 19 7004 7009 2-s2.0-44349124725 10.1073/pnas.0801615105 (Pubitemid 351754520)
97. Yang H., Kong W., He L., Zhao J.-J., O'Donnell J. D., Wang J., Wenham R. M., Coppola D., Kruk P. A., Nicosia S. V., Cheng J. Q., MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research 2008 68 2 425 433 2-s2.0-39049086391 10.1158/0008-5472.CAN-07-2488 (Pubitemid 351380068)
98. Eitan R., Kushnir M., Lithwick-Yanai G., David M. B., Hoshen M., Glezerman M., Hod M., Sabah G., Rosenwald S., Levavi H., Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecologic Oncology 2009 114 2 253 259 2-s2.0-67549139894 10.1016/j.ygyno.2009.04.024
99. Yang D., Sun Y., Hu L., Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 2013 23 2 186 199 10.1016/j.ccr.2012.12.020
100. Yang N., Kaur S., Volinia S., Greshock J., Lassus H., Hasegawa K., Liang S., Leminen A., Deng S., Smith L., Johnstone C. N., Chen X.-M., Liu C.-G., Huang Q., Katsaros D., Calin G. A., Weber B. L., Bützow R., Croce C. M., Coukos G., Zhang L., MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Research 2008 68 24 10307 10314 2-s2.0-57749105325 10.1158/0008-5472.CAN-08-1954
101. Kumar S., Kumar A., Shah P. P., Rai S. N., Panguluri S. K., Kakar S. S., MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines. Journal of Ovarian Research 2011 4 1, article 17 2-s2.0-80053174012 10.1186/1757-2215-4-17
102. Shahab S. W., Matyunina L. V., Hill C. G., Wang L., Mezencev R., Walker L. D., McDonald J. F., The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated. BMC Medical Genomics 2012 5, article 33
103. Morani F., Titone R., Pagano L., Galetto A., Alabiso O., Aimaretti G., Isidoro C., Autophagy and thyroid carcinogenesis: genetic and epigenetic links. Endocrine-Related Cancer 2013 21 1 R13 R29
104. Arico S., Petiot A., Bauvy C., Dubbelhuis P. F., Meijer A. J., Codogno P., Ogier-Denis E., The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. The Journal of Biological Chemistry 2001 276 38 35243 35246 2-s2.0-0035929650 10.1074/jbc.C100319200
105. Tay Y., Kats L., Salmena L., Weiss D., Tan S. M., Ala U., Karreth F., Poliseno L., Provero P., Di Cunto F., Lieberman J., Rigoutsos I., Pandolfi P. P., Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 2011 147 2 344 357 2-s2.0-80054700538 10.1016/j.cell.2011.09.029
106. Lou Y., Yang X., Wang F., Cui Z., Huang Y., MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. International Journal of Molecular Medicine 2010 26 6 819 827 2-s2.0-78649919224 10.3892/ijmm-00000530
107. Friedman R. C., Farh K. K.-H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
108. John B., Enright A. J., Aravin A., Tuschl T., Sander C., Marks D. S., Human microRNA targets. PLoS Biology 2004 2 11, article e363 2-s2.0-14044251458 10.1371/journal.pbio.0020363 (Pubitemid 40280484)
109. Frankel L. B., Wen J., Lees M., Høyer-Hansen M., Farkas T., Krogh A., Jäättelä M., Lund A. H., microRNA-101 is a potent inhibitor of autophagy. The EMBO Journal 2011 30 22 4628 4641
110. Semaan A., Qazi A. M., Seward S., Chamala S., Bryant C. S., Kumar S., Morris R., Steffes C. P., Bouwman D. L., Munkarah A. R., Weaver D. W., Gruber S. A., Batchu R. B., MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21waf1/cip1. Pharmaceutical Research 2011 28 12 3079 3090 2-s2.0-83555165019 10.1007/s11095-011-0547-x
111. Sonego M., Schiappacassi M., Lovisa S., Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. EMBO Molecular Medicine 2013 5 2 707 722 10.1002/emmm.201470020
112. Zhao Z., Liu X.-F., Wu H.-C., Zou S.-B., Wang J.-Y., Ni P.-H., Chen X.-H., Fan Q.-S., Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal growth factor signaling pathway. Cancer Science 2010 101 6 1454 1462 2-s2.0-77954169426 10.1111/j.1349-7006.2010.01558.x
113. Jia W., Eneh J. O., Ratnaparkhe S., Altman M. K., Murph M. M., MicroRNA-30c-2 expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9. Molecular Cancer Research 2011 9 12 1732 1745 2-s2.0-84055172752 10.1158/1541-7786.MCR-11-0245
114. Lee H., Park C. S., Deftereos G., Morihara J., Stern J. E., Hawes S. E., Swisher E., Kiviat N. B., Feng Q., MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World Journal of Surgical Oncology 2012 10, article 174
115. Marchini S., Cavalieri D., Fruscio R., Calura E., Garavaglia D., Nerini I. F., Mangioni C., Cattoretti G., Clivio L., Beltrame L., Katsaros D., Scarampi L., Menato G., Perego P., Chiorino G., Buda A., Romualdi C., D'Incalci M., Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. The Lancet Oncology 2011 12 3 273 285 2-s2.0-79952041791 10.1016/S1470-2045(11)70012-2
116. Degenhardt K., Mathew R., Beaudoin B., Bray K., Anderson D., Chen G., Mukherjee C., Shi Y., Gélinas C., Fan Y., Nelson D. A., Jin S., White E., Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006 10 1 51 64 2-s2.0-33745713171 10.1016/j.ccr.2006.06.001
117. Rosenfeldt M. T., Ryan K. M., The role of autophagy in tumour development and cancer therapy. Expert Reviews in Molecular Medicine 2009 11 e36 10.1017/S1462399409001306 2-s2.0-77951649035
118. Mezzanzanica D., Canevari S., Cecco L. D., Bagnoli M., miRNA control of apoptotic programs: focus on ovarian cancer. Expert Review of Molecular Diagnostics 2011 11 3 277 286 2-s2.0-79953829678 10.1586/erm.11.1